Skip to main content
. 2021 Apr 1;13(7):1630. doi: 10.3390/cancers13071630

Figure 3.

Figure 3

Comparison of outcomes in COVID-19-positive prostate cancer vs. non-prostate GU cancer (bladder and kidney) patients. Data presented in the clustered bar chart show higher rate of hospitalization, ICU admits, intubation, and mortality in prostate cancer patients with COVID-19.